Genstar Capital Buys eResearch Technology
Genstar Capital, a middle-market private equity firm, is paying $8.00 per share in cash to buy eResearchTechnology Inc., a provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations. The transaction is valued at roughly $400 million. PRESS RELEASE eResearchTechnology, Inc., a global technology-driven provider of health outcomes research services to biopharmaceutical...
Be very, very quiet – we’re hunting AIGs
As part of the Dodd-Frank Act, various types of participants in derivatives markets need to be defined. According to the jersey one ultimately gets as a trader of interest rate swaps,...
Probably not cool: getting inside info via your recovery buddy
Dear readers,Okay, seems some of you didn’t especially like Paul’s take on the FSA’s “charades” inside information case on Tuesday. Well the SEC...
Provista Diagnostics Inks $5M Series A
Provista Diagnostics Inc. has raised $5 million in Series A financing to help complete a confirmatory clinical trial, as well as to pay down debt. The company, based in Phoenix, is developing technology to detect and diagnose cancer. Terms of the financing were not released. PRESS RELEASE Provista Diagnostics, Inc. (“Provista” or the “Company”) today...
Provista Diagnostics Inks $5M Series A
Provista Diagnostics Inc. has raised $5 million in Series A financing to help complete a confirmatory clinical trial, as well as to pay down debt. The company, based in Phoenix, is developing technology to detect and diagnose cancer. Terms of the financing were not released. PRESS RELEASE Provista Diagnostics, Inc. (“Provista” or the “Company”) today...
Oppenheimer Fund in Valuation Inquiry
Federal regulators are investigating whether a private equity fund that was part of Oppenheimer Holdings Inc. overstated the value of one of its holdings, the Wall Street Journal wrote Friday. The case involves Oppenheimer Global Resource Private Equity Fund LP, which makes investments of its own and invests in other private equity funds, Reuters wrote....
Editorialising, SEC-style
Maybe we are making too much of this, but when the SEC is on its 30th or so figurative lynching related to the Galleon rat case, does it really need to juice up its press releases...
American swap regulation: a class apart
Take a moment to imagine what it must be like to be an American regulator. There are plenty to imagine being: the OCC, the Fed, the CFTC, SEC, FDIC, and that thrift one, until...
Ballard Spahr Expands
Ballard Spahr has expanded its litigation, real estate, and public finance capability in the Southeast with five Atlanta attorneys. Partners Han C. Choi, Ethan H. Cohen, Byung J. Pak, and Tracy S. Plott, and of counsel Isidor J. Kim represent regional, national, and international clients, including banks, financial services firms, life science and technology companies,...
Bighead leaves SEC
Extract:While I will miss doing this important work, I am gratified knowing that nearly every aspect of the SEC has been significantly improved in the four years since I was named Inspector General....
